Several reports suggest that HTLV-I/HIV coinfection may be associated with an increased
risk of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). In HTLV-I …

Human T-lymphotropic virus type I (HTLV-I) and HTLV-II have been postulated to accelerate
disease progression in patients coinfected with HIV. However, recent evidence suggests that …

To determine whether human T-lymphotropic virus (HTLV) type II coinfection affects
progression of human immunodeficiency virus type 1 (HIV) infection, longitudinal data on …

Background: HTLV-1/HIV co-infection is known to elevate the CD4+ T-cell counts of
treatment-naïve persons. We investigated whether HTLV-1/HIV co-infected patients …

The goal of this study was to investigate clinical outcomes and survival probabilities among
persons coinfected with human immunodeficiency virus (HIV) and human T lymphotropic …

We studied the prevalence of antibodies against HTLV-1 among every HIV-infected
outpatients assisted in our hospital between January 1st 2000 and June 30th 2003. We …

People living with HIV-1 and HTLV-2 concomitantly show slower CD4+ T cell depletion and
AIDS progression, more frequency of the natural control of HIV-1, and lower mortality rates …

Introduction Human T-lymphotropic virus type 1 or 2 (HTLV-1/2) co-infection in patients
infected with the human immunodeficiency virus (HIV) can lead to increased morbidity …

Co-infection with HTLV-1 reaches 20% among patients infected by HIV-1 in Bahia, Brazil. To
evaluate its impact on survival, we conducted a retrospective, case–control study involving …

Human T-cell lymphotropic virus (HTLV) type II has spread among intravenous drug users
(IDUs), many of whom are coinfected with HIV-1. We have investigated the rate of HTLV-II …